Intuitive Surgical Management
Management criteria checks 3/4
Intuitive Surgical's CEO is Gary Guthart, appointed in Jan 2010, has a tenure of 14.83 years. total yearly compensation is $12.45M, comprised of 7.7% salary and 92.3% bonuses, including company stock and options. directly owns 0.35% of the company’s shares, worth $687.69M. The average tenure of the management team and the board of directors is 2.8 years and 6.4 years respectively.
Key information
Gary Guthart
Chief executive officer
US$12.4m
Total compensation
| CEO salary percentage | 7.7% |
| CEO tenure | 14.8yrs |
| CEO ownership | 0.4% |
| Management average tenure | 2.8yrs |
| Board average tenure | 6.4yrs |
Recent management updates
Recent updates
Intuitive Surgical: One Of The Best Business Models In The World, But Not At This Price
Nov 14Intuitive Surgical Q3: Da Vinci 5 Robot Set For 2025, But Overvalued
Oct 18Intuitive Surgical (NASDAQ:ISRG) Is Reinvesting At Lower Rates Of Return
Oct 04
Intuitive Surgical Offers Low Risk, High Return Despite Valuation Concerns
Sep 24What You Can Learn From Intuitive Surgical, Inc.'s (NASDAQ:ISRG) P/S
Sep 16Intuitive Surgical: Detached From Fundamentals
Aug 26Intuitive Surgical: A Lofty Price To Pay For Innovation, Wait For A Better Entry Point
Aug 20There May Be Underlying Issues With The Quality Of Intuitive Surgical's (NASDAQ:ISRG) Earnings
Jul 26Intuitive Surgical: Shares Surge, But Now Near Fair Value (Rating Downgrade)
Jul 12Does Intuitive Surgical (NASDAQ:ISRG) Deserve A Spot On Your Watchlist?
Jul 11There Are Reasons To Feel Uneasy About Intuitive Surgical's (NASDAQ:ISRG) Returns On Capital
Jun 25What Is Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Share Price Doing?
Jun 10Intuitive Surgical: Sell Signals Abound
May 17Intuitive Surgical, Inc.'s (NASDAQ:ISRG) CEO Compensation Looks Acceptable To Us And Here's Why
Apr 19Intuitive Surgical: Growth And Margins Will Be Challenged In 2024
Apr 12Intuitive Surgical (NASDAQ:ISRG) Will Want To Turn Around Its Return Trends
Mar 27Is It Too Late To Consider Buying Intuitive Surgical, Inc. (NASDAQ:ISRG)?
Mar 11Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Earnings Haven't Escaped The Attention Of Investors
Feb 09Intuitive Surgical: Buy A 'Little Slice' Of The Future
Jan 29Do Intuitive Surgical's (NASDAQ:ISRG) Earnings Warrant Your Attention?
Jan 25Intuitive Surgical: Strong Pre-Announced Q4 - Time To Harvest The Gain, Initiate With 'Sell'
Jan 13Some Investors May Be Worried About Intuitive Surgical's (NASDAQ:ISRG) Returns On Capital
Dec 10At US$318, Is Intuitive Surgical, Inc. (NASDAQ:ISRG) Worth Looking At Closely?
Nov 25Should You Be Adding Intuitive Surgical (NASDAQ:ISRG) To Your Watchlist Today?
Oct 25Are Intuitive Surgical, Inc. (NASDAQ:ISRG) Investors Paying Above The Intrinsic Value?
Sep 22What Does Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Share Price Indicate?
Aug 04There Are Reasons To Feel Uneasy About Intuitive Surgical's (NASDAQ:ISRG) Returns On Capital
Jul 17Intuitive Surgical (NASDAQ:ISRG) Might Be Having Difficulty Using Its Capital Effectively
Apr 08Is There Now An Opportunity In Intuitive Surgical, Inc. (NASDAQ:ISRG)?
Jan 26There Are Reasons To Feel Uneasy About Intuitive Surgical's (NASDAQ:ISRG) Returns On Capital
Jan 08Is Intuitive Surgical, Inc. (NASDAQ:ISRG) Worth US$272 Based On Its Intrinsic Value?
Dec 03Intuitive Surgical: Risky Ahead Of Q3 Earnings
Oct 16Is It Too Late To Consider Buying Intuitive Surgical, Inc. (NASDAQ:ISRG)?
Oct 11Japanese regulatory agency clears Intuitive's single-port robotic surgical system
Sep 30Returns On Capital At Intuitive Surgical (NASDAQ:ISRG) Paint A Concerning Picture
Sep 26Intuitive Surgical: Fundamentally Fairly Valued, Technically Risky (Technical Analysis)
Sep 23Intuitive Surgical: Raising The Red Flag On The Hospital Industry
Aug 23Estimating The Intrinsic Value Of Intuitive Surgical, Inc. (NASDAQ:ISRG)
Jul 26Intuitive Surgical to report Q2 result amid persistent COVID-19 headwinds
Jul 20Should You Think About Buying Intuitive Surgical, Inc. (NASDAQ:ISRG) Now?
Jul 11Intuitive Surgical: Quite Invasive
Jul 06Returns On Capital Signal Tricky Times Ahead For Intuitive Surgical (NASDAQ:ISRG)
Jun 27Intuitive Surgical Is Getting Close To Fair Value After Years Of Overvaluation
Jun 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$2b |
| Jun 30 2024 | n/a | n/a | US$2b |
| Mar 31 2024 | n/a | n/a | US$2b |
| Dec 31 2023 | US$12m | US$955k | US$2b |
| Sep 30 2023 | n/a | n/a | US$2b |
| Jun 30 2023 | n/a | n/a | US$1b |
| Mar 31 2023 | n/a | n/a | US$1b |
| Dec 31 2022 | US$10m | US$873k | US$1b |
| Sep 30 2022 | n/a | n/a | US$1b |
| Jun 30 2022 | n/a | n/a | US$1b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$8m | US$846k | US$2b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | n/a | n/a | US$2b |
| Mar 31 2021 | n/a | n/a | US$1b |
| Dec 31 2020 | US$6m | US$821k | US$1b |
| Sep 30 2020 | n/a | n/a | US$1b |
| Jun 30 2020 | n/a | n/a | US$1b |
| Mar 31 2020 | n/a | n/a | US$1b |
| Dec 31 2019 | US$6m | US$790k | US$1b |
| Sep 30 2019 | n/a | n/a | US$1b |
| Jun 30 2019 | n/a | n/a | US$1b |
| Mar 31 2019 | n/a | n/a | US$1b |
| Dec 31 2018 | US$6m | US$767k | US$1b |
| Sep 30 2018 | n/a | n/a | US$804m |
| Jun 30 2018 | n/a | n/a | US$810m |
| Mar 31 2018 | n/a | n/a | US$778m |
| Dec 31 2017 | US$5m | US$744k | US$671m |
Compensation vs Market: Gary's total compensation ($USD12.45M) is about average for companies of similar size in the US market ($USD12.66M).
Compensation vs Earnings: Gary's compensation has increased by more than 20% in the past year.
CEO
Gary Guthart (58 yo)
14.8yrs
Tenure
US$12,449,381
Compensation
Dr. Gary S. Guthart, Ph.D. has been Chief Executive Officer of Intuitive Surgical, Inc. since January 1, 2010 and was its President since July 12, 2007. Dr. Guthart served as the Chief Operating Officer at...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 14.8yrs | US$12.45m | 0.35% $ 687.7m | |
| President & Director | 1.5yrs | US$12.56m | 0.060% $ 116.1m | |
| Senior VP & CFO | 2.8yrs | US$5.03m | 0.0025% $ 4.8m | |
| Senior VP & Chief Commercial and Marketing Officer | 1.5yrs | US$5.10m | 0.00084% $ 1.6m | |
| Executive VP and Chief Strategy & Corporate Operations Officer | 9yrs | US$4.84m | 0.0015% $ 3.0m | |
| VP, Principal Accounting Officer & Corporate Controller | 4.8yrs | no data | 0.000030% $ 58.5k | |
| VP, Treasurer & Head of Investor Relations | no data | no data | no data | |
| Senior VP | 2.2yrs | no data | 0.00085% $ 1.7m | |
| Executive Vice President of Research | less than a year | no data | no data | |
| Chief Human Resources Officer | less than a year | no data | no data | |
| Executive VP & Chief Medical Officer | 10.8yrs | US$4.48m | 0.000080% $ 156.1k | |
| Executive VP & Chief Digital Officer | 9.4yrs | no data | 0.0020% $ 3.9m |
2.8yrs
Average Tenure
57yo
Average Age
Experienced Management: ISRG's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 15.6yrs | US$12.45m | 0.35% $ 687.7m | |
| President & Director | less than a year | US$12.56m | 0.060% $ 116.1m | |
| Independent Director | 14.6yrs | US$388.12k | 0.0034% $ 6.7m | |
| Independent Director | 4.6yrs | US$379.79k | 0.00067% $ 1.3m | |
| Independent Chairman | 13.6yrs | US$498.74k | 0.0073% $ 14.3m | |
| Director | less than a year | no data | 0.000010% $ 19.5k | |
| Independent Director | 7.6yrs | US$383.12k | 0.0016% $ 3.1m | |
| Independent Director | 8.8yrs | US$379.79k | 0.00045% $ 878.1k | |
| Independent Director | 5.3yrs | US$376.79k | 0.00023% $ 448.8k | |
| Independent Director | 17.1yrs | US$392.46k | 0.0045% $ 8.8m | |
| Independent Director | 3.6yrs | US$376.79k | 0.00045% $ 878.1k | |
| Independent Director | 1.1yrs | US$142.84k | 0.000070% $ 136.6k |
6.4yrs
Average Tenure
61.5yo
Average Age
Experienced Board: ISRG's board of directors are considered experienced (6.4 years average tenure).